Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Monteris Medical Corporation is managing 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. Both of these actions are located in 1 distinct art unit, suggesting a consistent technological focus for the company's current filings. The portfolio involves 2 distinct examiners. The 1 distinct art unit involved provides a singular administrative environment for both of the 2 pending office actions.
FLANAGAN, BEVERLY MEINDL is the busiest examiner, overseeing 1 pending office action. This represents a portion of the 2 pending office actions in the total portfolio. Because 2 distinct examiners are working within the same 1 distinct art unit, the company must navigate two different examiner styles within a single administrative division. FLANAGAN, BEVERLY MEINDL is one of the 2 distinct examiners involved.
The presence of 2 distinct examiners within 1 distinct art unit requires a strategy that accounts for different examiner preferences on related medical device technology. While FLANAGAN, BEVERLY MEINDL manages 1 pending office action, the other action is handled by a second examiner. This structure allows the company to compare examiner feedback within the same 1 distinct art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLANAGAN, BEVERLY MEINDL | 1 | 73.0% | +20.4% |
| AVIGAN, ADAM JOSEPH | 1 | 43.7% | +16.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17804364 | CRYOTHERAPY, THERMAL THERAPY, TEMPERATURE MODULATION THERAPY, AND PROBE APPARATUS THEREFOR | AVIGAN, ADAM JOSEPH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18642684 | SURGICAL PROBE DEVICE, AND SYSTEMS AND METHODS FOR COOLING THE SAME | FLANAGAN, BEVERLY MEINDL | 9d |
| 17804364 | CRYOTHERAPY, THERMAL THERAPY, TEMPERATURE MODULATION THERAPY, AND PROBE APPARATUS THEREFOR | AVIGAN, ADAM JOSEPH | — |
| Art Unit | Apps |
|---|---|
| 3794 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18642684 | SURGICAL PROBE DEVICE, AND SYSTEMS AND METHODS FOR COOLING THE SAME | FLANAGAN, BEVERLY MEINDL | 3794 | §103 | Final Rejection | 9d | Pending | Apr 22, 2024 |
| 17804364 | CRYOTHERAPY, THERMAL THERAPY, TEMPERATURE MODULATION THERAPY, AND PROBE APPARATUS THEREFOR | AVIGAN, ADAM JOSEPH | 3794 | §102§103§112 | Non-Final OA | — | Pending | May 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial